Jay Barth
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Gastroesophageal reflux and treatments, Helicobacter pylori-related gastroenterology studies, Carbohydrate Chemistry and Synthesis, Glycogen Storage Diseases and Myoclonus
Most-Cited Works
- → Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat(2016)543 cited
- → Ataluren treatment of patients with nonsense mutation dystrophinopathy(2014)426 cited
- → Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study(2016)380 cited
- → Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial(2014)334 cited
- → THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study(2013)297 cited
- → Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy(2013)241 cited
- → The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat(2016)207 cited
- → Seven‐day therapy for Helicobacter pylori in the United States(2004)171 cited
- → Colorectal Adenocarcinoma in Crohn's Disease(1996)110 cited
- → Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study(2019)94 cited